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The Commonwealth of Massachusetts 
Executive Office of Health and Human Services 
Department of Public Health 
Bureau of Health Care Safety and Quality 
99 Chauncy Street, 11th Floor Boston, MA 02111 
  
TO:  Chief Executive Officers, Maternity Hospitals and Birthing Centers 
 
FROM: Madeleine Biondolillo, MD, Director, Bureau of Health Care Safety and Quality  
 
CC:   Marlene Anderka, ScD, MPH, Director, Massachusetts Center for Birth Defects Research 
and Prevention 
Ron Benham, Director, Bureau of Family Health and Nutrition 
 
DATE: June 21, 2013 
 
RE:   Amendment of Circular Letter # 13-5-590 (Screening for Critical Congenital Heart 
Disease in Infants) 
 
 
The purpose of this letter is to clarify the above referenced guidance regarding screening for Critical 
Congenital Heart Disease (CCHD) in newborns using pulse oximetry, previously circulated to Maternity 
Hospitals and Birthing Centers. Specifically, the CCHD Pulse Oximetry Screening and Reporting 
Factsheet and Algorithm have been amended to clarify that “newborn nursery” includes both well-
newborn nurseries (Level IA and IB) and special care nurseries (Level IIA and IIB).  An amended 
Factsheet and Algorithm is attached.  
 
If you have questions about the information in this correspondence, please contact Marlene Anderka at 
617-624-6045 or email Marlene.Anderka@state.ma.us. 
 
We request that you forward this clarification and revised Factsheet to the following staff at your 
hospital, and any others as appropriate: Chief Medical Officer, Chief of Obstetrics, Chief of 
Pediatrics, Chief of Neonatology, Chief Nursing Officer, Director of Maternal and Child Health, 
and QA Director/Risk Manager. 
 
 
 
 
Enclosure:   CCHD Pulse Oximetry Screening and Reporting Factsheet 
 
 
